• Facebook
  • Twitter
  • Instagram
  • Youtube
  • Linkedin
AIM Leader
  • Cover Story
  • Features
  • AIM News
  • Alumni News
  • Multimedia
  • Life At AIM
  • Contact
  • Give
Select Page
Share on FacebookShare on Twitter
Articles

Sarva Pharmaceuticals: International Expansion to Myanmar

by AIM Research and Publication

Reaserch by: Sandeep Puri, Sven Dahms, Shraddha Puri, & Ritvik Nalamothu 

 

Abstract 

 In 2019, the managing director of Sarva Pharmaceuticals Private Limited, a pharmaceutical company based in India, was considering an expansion of his company by entering the growing pharmaceutical market in Myanmar. He needed to identify the best way to execute this expansion plan, assess whether his company’s product range was adequate and suitable for the Myanmar market, prepare for possible risks and cross-cultural marketing issues, and plan the management staffing approaches in Myanmar. 

 

Learning Objective

This case is suitable for graduate-level courses on international marketing, international business, analysis of business opportunity analysis, or marketing strategy. It can also be used to facilitate discussions on market entry strategies for international markets, including exporting, licensing, and joint ventures. After working through the case and assignment questions, students will be able to 

  • analyze macro-environmental and competitive forces in international marketing; 
  • evaluate various strategies for entering international markets; 
  • discuss various management staffing approaches in international marketing; and 
  • appreciate the importance of cross-cultural marketing issues in international marketing. 

 

Issues: international marketing, international business, cross-cultural marketing, international staffing 

 

Disciplines: Marketing,  Entrepreneurship,  International 

 

Industries: Wholesale Trade 

 

Setting: Mozambique; Myanmar, Small, 2019 

 

Intended Audience: MBA/Postgraduate 

 

To cite this case: Puri, S., Dahms, S., Puri, S., & Nalamothu, Ritvik. (2020). Sarva Pharmaceuticals: International expansion to Myanmar. Ivey ID: 9B20A016. London, Canada: Ivey Publishing. 

 

To access this case: https://www.iveycases.com/ProductView.aspx?id=108610 

Related Articles

Faculty
December 8, 2022
An Order Allocation Methodology Based on Customer Repurchase Motivation Drivers Using Blockchain Technology
Research by: Qi Sun, Ming Dong, & Albert Tan   Executive Summary In the e-commerce market, the cost of customer acquisiti...
by AIM Research and Publication
Faculty
November 24, 2022
Portfolio Optimization Considering Behavioral Stocks with Return Scenario Generation
Research by: Michael N. Young, TJ Troy N. Chuahay, Yen-Hsien Lee, John Francis T. Diaz, Yogi Tri Prasetyo, Satria Fadil Persada, &...
by AIM Research and Publication
Centers
October 28, 2022
Re-thinking Governance in Tourism: Harnessing Tourism’s Post-Covid-19 Economic Potential
Research by: John Paolo R. Rivera, Eylla Laire M. Gutierrez, & Fernando Martin Y. Roxas Executive Summary In reviewing existin...
by AIM Research and Publication
AIM Logo

Learn how business works in Asia with the people who practice it.

  • Cover Story
  • Multimedia
  • Features
  • Life at AIM
  • AIM News
  • Contact
  • Alumni News
  • Give
Copyright © Asian Institute of Management 2021 | Privacy Policy
  • Facebook
  • Twitter
  • Instagram
  • Youtube
  • Linkedin